Kineret in the Treatment of Rheumatoid Arthritis

Sobi

Status

Completed

Conditions

Rheumatoid Arthritis

Treatments

Drug: Anakinra

Study type

Observational

Funder types

Industry

Identifiers

NCT02915094

KIRA

Details and patient eligibility

About

Objective of the study is to gain knowledge about the administration of Kineret in patients with rheumatoid arthritis in the daily routine treatment and not in controlled trials. In the current survey, the investigation of the response rate of Kineret regarding the date of onset of action, the efficacy, as well as the tolerability and safety are of particular interest.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria